Any person exploiting a medicinal product or product mentioned in Article L. 5121-1 or any holder of the authorisation provided for in Article L. 4211-6 who fails to comply with the obligations to report a serious adverse reaction suspected to be due to this medicinal product or product of which he has been made aware is liable to two years’ imprisonment and a fine of €150,000.